HUMAX-CD20, created in 2006 (Denmark), from 10 sister brands and 2214 competing brands. HUMAX-CD20's notoriety arose from exemplary management which optimizes product quality and client satisfaction, which in turn generate financial performance, and therefore, stock performance. Being a Popular brand online is assessed based on the evolution of worldwide Web searches over the last five years.
Buy Genmab share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.
- The following interest graph for HUMAX-CD20 shows the evolution of worldwide Web searches in the last five years. The graph shows the evolution of HUMAX-CD20 search rates over time, with a value of 100 indicating the month when it was highest.
- Compare the 5-year Web notoriety graph with the 5-year market price graph:
- Notoriety -> Market prices
